1994
DOI: 10.1016/0020-1693(94)04031-1
|View full text |Cite
|
Sign up to set email alerts
|

Electrochemical, photophysical and photochemical properties of a hexanuclear ruthenium(II) bis(2,2′-bipyridyl) complex containing a tris(pyrazyltriazole)benzene ligand

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

1998
1998
2007
2007

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 28 publications
1
5
0
Order By: Relevance
“…the dipyridopyrazine family of complexes), are pyrazine-based; however, few detailed studies have been carried out to confirm this 6f. The emission spectra of 1 and H 2 1 are comparable with those reported for the related complexes (see Figure and Table ) [Ru(bpy) 2 (μ-1Mepztr)Ru(bpy) 2 Cl] 3+ ( 6 ) 13e and [(Ru(bpy) 2 ) 3 ((pztr) 3 ph)(Ru(bpy) 2 Cl) 3 ] 6+ ( 8 ) . The red shift observed upon protonation is in agreement with the stabilization of the pyrazine-based LUMO; however, assignment of the emitting state as pyrazine-based is not so clear since a significant isotope effect on the emission lifetimes for 1 and H 2 1 (at 298 and 77 K) is observed upon deuteriation of the bpy ligands (Table ).…”
Section: Discussionsupporting
confidence: 66%
See 1 more Smart Citation
“…the dipyridopyrazine family of complexes), are pyrazine-based; however, few detailed studies have been carried out to confirm this 6f. The emission spectra of 1 and H 2 1 are comparable with those reported for the related complexes (see Figure and Table ) [Ru(bpy) 2 (μ-1Mepztr)Ru(bpy) 2 Cl] 3+ ( 6 ) 13e and [(Ru(bpy) 2 ) 3 ((pztr) 3 ph)(Ru(bpy) 2 Cl) 3 ] 6+ ( 8 ) . The red shift observed upon protonation is in agreement with the stabilization of the pyrazine-based LUMO; however, assignment of the emitting state as pyrazine-based is not so clear since a significant isotope effect on the emission lifetimes for 1 and H 2 1 (at 298 and 77 K) is observed upon deuteriation of the bpy ligands (Table ).…”
Section: Discussionsupporting
confidence: 66%
“…6f The emission spectra of 1 and H 2 1 are comparable with those reported for the related complexes (see Figure 2 and Table 1) [Ru(bpy) 2 (µ-1Mepztr)Ru(bpy) 2 Cl] 3+ (6) 13e and [(Ru(bpy) 2 ) 3 ((pztr) 3 ph)(Ru(bpy) 2 Cl) 3 ] 6+ (8). 49 The red shift observed upon protonation is in agreement with the stabilization of the pyrazine-based LUMO; however, assignment of the emitting state as pyrazine-based is not so clear since a significant isotope effect on the emission lifetimes for 1 and H 2 1 (at 298 and 77 K) is observed upon deuteriation of the bpy ligands (Table 1). In previous studies of heteroleptic complexes, deuteriation of the ligands on which the lowest excited state is based results in an increase in emission lifetime.…”
Section: Discussionmentioning
confidence: 99%
“…300-350 mV per proton) of the redox potentials reported for ruthenium, osmium and iron complexes with the ligands bearing multi-imidazolyl and -benzimidazolyl units, [9,[14][15][16] but similar to the shift (350-420 mV) of the Ru II /Ru III oxidation potentials reported for monoruthenium complexes with two bpy ligands and one triazole-or pyrazole-containing ligand. [21,23,29,30] …”
Section: Resultsmentioning
confidence: 98%
“…[13][14][15][16][17][18][19] In addition to the imidazole-containing ligands, mono-and dinuclear ruthenium complexes with ligands bearing triazole and pyrazole units were also extensively studied for their interesting electrochemical and photophysical properties. [20][21][22][23][24] In this communication, we …”
Section: Introductionmentioning
confidence: 97%
“…Ruthenium(II) and osmium(II) complexes of this sort of ligand are of considerable interest because their redox, absorption, and emission properties can be subjected to fine-tuning by control of pH. Indeed, in a few cases proton-induced switching phenomena have been reported. , To this end, complexes of the bridging ligands 2,2‘-bis(2-pyridyl)bibenzimidazole, , 2,6-bis(2‘-pyridyl)benzdiimidazole, 16b, 2,2‘-bis(2-benzimidazolyl)-4,4‘-bipyridine, , 1,3,5-tris[5-(pyridin-2-yl)-1,2,4-triazol-3-yl]benzene, and 1,3,5-tris[5-(pyrazin-2-yl)-1,2,4-triazol-3-yl]benzene 18 in combination with 2,2‘-bipyridine (bpy) or 1,10-phenanthroline (phen) have been studied extensively.…”
Section: Introductionmentioning
confidence: 99%